237690.KQ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 09:30):

Stats
Dzisiejszy wolumen	73 713.00
Średni wolumen	243 139
Kapitalizacja rynkowa	1 622.64B
EPS	KRW0 ( 2024-02-13 )
Następna data zysków	( KRW355.90 ) 2024-04-30
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW167.57 (0.20%)

Wolumen Korelacja

Długi: -0.26 (neutral)

Krótki: 0.39 (neutral)

Signal:(55.45) Neutral

ST Pharm Co.,Ltd. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ST Pharm Co.,Ltd. Korelacja - Waluta/Towar

-0.28
( neutral )

0.01
( neutral )

0.59
( weak )

-0.10
( neutral )

0.06
( neutral )

0.49
( neutral )

ST Pharm Co.,Ltd. Finanse

Annual	2023
Przychody:	KRW284.99B
Zysk brutto:	KRW106.63B (37.41 %)
EPS:	KRW1 041.07

FY	2023
Przychody:	KRW284.99B
Zysk brutto:	KRW106.63B (37.41 %)
EPS:	KRW1 041.07

FY	2022
Przychody:	KRW249.32B
Zysk brutto:	KRW83.28B (33.40 %)
EPS:	KRW957.00

Financial Reports:

No articles found.

ST Pharm Co.,Ltd.

ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It also provides oligonucleotide based products, such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and other products; and monomer/phosphoramidite. In addition, the company offers generic APIs for anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD, cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction medicines, as well as MRI contrast agents. Further, it provides 2nd battery, electronic materials, and polymer catalysts. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is based in Seoul, South Korea.

Aktualne aktualizacje dla ST Pharm Co.,Ltd. [237690.KQ]

Upcoming Earnings Alert